Skip to content
The Kids Research Institute Australia logo

Dr Sung Chiu

Postdoctoral Research Fellow

Sung Chiu

Postdoctoral Research Fellow

MBBS FRACP FRCPA PhD

sung.chiu@thekids.org.au

Sung is an early-career clinician-scientist who completed a PhD in the Australian Centre for Blood Diseases (Monash University, supported by the Leukaemia Foundation PhD scholarship) in 2020 using mouse models to study the role of transcription factors in blood production and acute lymphoblastic leukaemia. His work has resulted in first author publication in Blood, the number one ranked journal in haematology (Clarivate 2021).

Upon returning to Western Australia he has taken up a part-time post-doctoral position under the supervision of Dr Cheung and Associate Professor Kotecha. His work is focused on identifying novel therapies for high-risk acute lymphoblastic leukaemia.

He manages his research concurrently while also practising as a clinical and laboratory haematologist in SJOG Midland hospital looking after patients with leukaemias and other blood disorders; this provides him with a unique opportunity to directly translate his research findings into improved treatment for patients.

Find Dr Chiu on ORCID.

Published research

LYL1 is critical for adult hematopoietic stem cell-derived B and T lymphopoiesis

Hematopoietic stem cells are defined by their remarkable self-renewal and differentiation capacities, giving rise to progenitors that generate diverse blood and immune cell lineages through the tightly regulated process of hematopoiesis. This process is governed by key transcription factors that control gene expression programs essential for cellular homeostasis, differentiation, and lineage commitment. 

Published research Leukaemia Translational Research
Learn more about LYL1 is critical for adult hematopoietic stem cell-derived B and T lymphopoiesis

August 2026

Blinatumomab limits humoral antibody response despite boosting the influenza vaccine schedule in children with B-ALL

Published research Infectious Diseases Infectious Diseases Epidemiology Leukaemia Translational Research Immune system Respiratory viral infections
Learn more about Blinatumomab limits humoral antibody response despite boosting the influenza vaccine schedule in children with B-ALL

April 2026

Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia

Infants with KMT2A-rearranged B-cell acute lymphoblastic leukemia (ALL) have high rates of relapse and poor survival compared with children. Few new therapies have been identified over the past twenty years. The aim of this study was to identify existing anti-cancer agents that have the potential to be repurposed for the treatment of infant ALL.

Children's Cancers Published research Leukaemia Translational Research Translational Genomics in Leukaemia
Learn more about Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia

February 2025

Awards/Honours
  • 2022 – Early Career Investigator Grant, Cancer Council WA, Western Australia
  • 2022 – Research Establishment Fellowship, Royal Australasian College of Physicians, Australia
  • 2020 – Collaborative Cancer Grant, Cancer Council WA, Australia